Updated Guideline for using interferon gamma release assays to detect mycobacterium tuberculosis infection
MedSun: Newsletter #52, September 2010

CDC MMWR

This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.

Additional Information:

CDC MMWR. Updated Guideline for using interferon gamma release assays to detect mycobacterium tuberculosis infection. June 25, 2010.
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun